RILPIVIRINE

RILPIVIRINE was reported 7138 times

These side effects are most commonly reported by patients taking RILPIVIRINE:

# Side effect Count
0 INJECTION SITE PAIN 682
1 PRODUCT DOSE OMISSION ISSUE 670
2 VIRAL LOAD INCREASED 465
3 VIROLOGIC FAILURE 445
4 PATHOGEN RESISTANCE 352
5 PAIN 321
6 OFF LABEL USE 306
7 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 272
8 VIRAL MUTATION IDENTIFIED 244
9 BLOOD HIV RNA INCREASED 223
10 PYREXIA 186
11 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 184
12 PRODUCT COMPLAINT 177
13 EXPOSURE DURING PREGNANCY 176
14 PRODUCT STORAGE ERROR 176
15 FATIGUE 172
16 TREATMENT FAILURE 172
17 DRUG INTERACTION 160
18 INJECTION SITE NODULE 158
19 DRUG RESISTANCE 150
20 DEPRESSION 145
21 HEADACHE 139
22 NAUSEA 137
23 CONDITION AGGRAVATED 121
24 DRUG INEFFECTIVE 117
25 DIZZINESS 116
26 DIARRHOEA 115
27 RASH 114
28 MALAISE 109
29 MYALGIA 108
30 DYSPNOEA 103
31 TREATMENT NONCOMPLIANCE 103
32 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 103
33 ANXIETY 99
34 ARTHRALGIA 99
35 INCORRECT DOSE ADMINISTERED 99
36 HEPATITIS B 92
37 DEATH 91
38 VOMITING 89
39 WEIGHT DECREASED 89
40 INJECTION SITE REACTION 88
41 BACK PAIN 86
42 PRODUCT USE ISSUE 83
43 FOETAL EXPOSURE DURING PREGNANCY 81
44 INJECTION SITE MASS 77
45 HEPATITIS B REACTIVATION 75
46 INJECTION SITE SWELLING 74
47 INJECTION SITE DISCOMFORT 72
48 INSOMNIA 71
49 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 70
50 PAIN IN EXTREMITY 69
51 PRURITUS 67
52 NODULE 63
53 GAIT DISTURBANCE 60
54 PRODUCT USE IN UNAPPROVED INDICATION 60
55 SYNCOPE 60
56 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 59
57 WEIGHT INCREASED 58
58 ACUTE KIDNEY INJURY 57
59 HYPERTENSION 56
60 MUSCULOSKELETAL PAIN 55
61 ABORTION SPONTANEOUS 54
62 HYPERHIDROSIS 54
63 INJECTION SITE DISCHARGE 54
64 INJECTION SITE ERYTHEMA 54
65 FEELING HOT 52
66 ASTHENIA 51
67 CHILLS 51
68 FLUSHING 50
69 ABDOMINAL PAIN 49
70 INFLUENZA LIKE ILLNESS 49
71 ERYTHEMA 46
72 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 46
73 PRODUCT ADMINISTRATION ERROR 46
74 ERECTILE DYSFUNCTION 45
75 NEUROPATHY PERIPHERAL 45
76 MUSCLE SPASMS 44
77 URTICARIA 43
78 COUGH 42
79 INJECTION SITE INDURATION 42
80 PNEUMONIA 42
81 DRUG LEVEL DECREASED 41
82 HYPERSENSITIVITY 41
83 SOMNOLENCE 41
84 CD4 LYMPHOCYTES DECREASED 40
85 COVID-19 40
86 PARAESTHESIA 40
87 DEPRESSED MOOD 38
88 INJECTION SITE ABSCESS 38
89 PSYCHOTIC DISORDER 38
90 SUICIDAL IDEATION 38
91 AGGRESSION 36
92 DIABETES MELLITUS 36
93 DISCOMFORT 36
94 FEELING ABNORMAL 36
95 GAIT INABILITY 35
96 HEPATITIS C 35
97 HYPOTENSION 35
98 CHEST DISCOMFORT 34
99 SLEEP DISORDER 34
100 FALL 33
101 MOBILITY DECREASED 33
102 TOXICITY TO VARIOUS AGENTS 33
103 ANAPHYLACTIC REACTION 32
104 CHEST PAIN 32
105 VIRAEMIA 32
106 DECREASED APPETITE 31
107 INJECTION SITE WARMTH 31
108 MUSCULAR WEAKNESS 31
109 UNDERDOSE 31
110 HYPOAESTHESIA 30
111 ILLNESS 30
112 DYSLIPIDAEMIA 29
113 PRODUCT DISPENSING ERROR 29
114 SUBSTANCE USE 29
115 ABDOMINAL DISCOMFORT 28
116 ALOPECIA 28
117 BLOOD CREATININE INCREASED 28
118 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 28
119 ILL-DEFINED DISORDER 28
120 MYOCARDIAL INFARCTION 28
121 TACHYCARDIA 28
122 ABSCESS 27
123 ACCIDENTAL EXPOSURE TO PRODUCT 27
124 ALANINE AMINOTRANSFERASE INCREASED 27
125 CONGENITAL CYTOMEGALOVIRUS INFECTION 27
126 RENAL IMPAIRMENT 27
127 SUICIDE ATTEMPT 27
128 SYPHILIS 27
129 ABDOMINAL LYMPHADENOPATHY 26
130 ADVERSE DRUG REACTION 26
131 CRYPTOSPORIDIOSIS INFECTION 26
132 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 26
133 OCCUPATIONAL EXPOSURE TO PRODUCT 26
134 SCIATICA 26
135 DYSPHAGIA 25
136 HOSPITALISATION 25
137 ACUTE HEPATITIS B 24
138 HEPATIC ENZYME INCREASED 24
139 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24
140 LACTIC ACIDOSIS 24
141 LIVER FUNCTION TEST INCREASED 24
142 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 23
143 DRUG HYPERSENSITIVITY 23
144 DRUG INTOLERANCE 23
145 DYSPEPSIA 23
146 EXPOSURE VIA SKIN CONTACT 23
147 INJECTION SITE PRURITUS 23
148 LOSS OF CONSCIOUSNESS 23
149 NEUTROPENIA 23
150 PRESYNCOPE 23
151 TUBERCULOSIS 23
152 ADVERSE EVENT 22
153 CEREBROVASCULAR ACCIDENT 22
154 PRODUCT PREPARATION ISSUE 22
155 PULMONARY EMBOLISM 22
156 SWELLING 22
157 ANAEMIA 21
158 DEHYDRATION 21
159 LEUKOPENIA 21
160 LIPODYSTROPHY ACQUIRED 21
161 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21
162 MENTAL DISORDER 21
163 NEUROTOXICITY 21
164 RASH PRURITIC 21
165 ABDOMINAL PAIN UPPER 20
166 GLOMERULAR FILTRATION RATE DECREASED 20
167 HEPATITIS 20
168 NEPHROPATHY TOXIC 20
169 BLOOD PRESSURE INCREASED 19
170 PREMATURE BABY 19
171 BURNING SENSATION 18
172 CELLULITIS 18
173 INFECTION 18
174 INJECTION SITE HAEMORRHAGE 18
175 NASOPHARYNGITIS 18
176 PALPITATIONS 18
177 PRODUCT PREPARATION ERROR 18
178 TYPE 2 DIABETES MELLITUS 18
179 ASPARTATE AMINOTRANSFERASE INCREASED 17
180 ELECTROCARDIOGRAM QT PROLONGED 17
181 GASTROINTESTINAL DISORDER 17
182 MOOD ALTERED 17
183 NIGHT SWEATS 17
184 OROPHARYNGEAL PAIN 17
185 THERAPEUTIC RESPONSE UNEXPECTED 17
186 TREMOR 17
187 VIRAL LOAD ABNORMAL 17
188 BLOOD TRIGLYCERIDES ABNORMAL 16
189 CHRONIC KIDNEY DISEASE 16
190 DRY SKIN 16
191 GENE MUTATION 16
192 HEPATOTOXICITY 16
193 MATERNAL EXPOSURE DURING PREGNANCY 16
194 NEPHROLITHIASIS 16
195 OCULAR HYPERAEMIA 16
196 OEDEMA 16
197 OSTEOPOROSIS 16
198 VISUAL IMPAIRMENT 16
199 ABDOMINAL DISTENSION 15
200 ABNORMAL DREAMS 15
201 EMOTIONAL DISTRESS 15
202 EYE DISORDER 15
203 INJECTION SITE INFLAMMATION 15
204 INJECTION SITE OEDEMA 15
205 NIGHTMARE 15
206 RENAL FAILURE 15
207 MUSCULOSKELETAL STIFFNESS 14
208 PERIPHERAL SWELLING 14
209 SKIN LESION 14
210 STRESS 14
211 SWELLING FACE 14
212 THROMBOCYTOPENIA 14
213 TRANSPLANT REJECTION 14
214 WRONG PRODUCT ADMINISTERED 14
215 ABSCESS LIMB 13
216 COMPLETED SUICIDE 13
217 EXTRA DOSE ADMINISTERED 13
218 GASTROOESOPHAGEAL REFLUX DISEASE 13
219 GYNAECOMASTIA 13
220 INJECTION SITE INFECTION 13
221 IRRITABILITY 13
222 LETHARGY 13
223 LIP SWELLING 13
224 MASS 13
225 SEIZURE 13
226 SKIN EXFOLIATION 13
227 URINARY TRACT INFECTION 13
228 ACNE 12
229 ANGIOEDEMA 12
230 ANHEDONIA 12
231 CARDIAC FAILURE 12
232 CONSTIPATION 12
233 CONTUSION 12
234 DRUG LEVEL INCREASED 12
235 DYSGEUSIA 12
236 HAEMORRHAGE 12
237 HOT FLUSH 12
238 HYPERGLYCAEMIA 12
239 INDURATION 12
240 INJECTION SITE NECROSIS 12
241 MAJOR DEPRESSION 12
242 MONKEYPOX 12
243 MUSCLE ATROPHY 12
244 NECK PAIN 12
245 NERVOUS SYSTEM DISORDER 12
246 NEURALGIA 12
247 PROSTATE CANCER 12
248 RESPIRATORY FAILURE 12
249 RHINORRHOEA 12
250 SKIN MASS 12
251 THERAPY CESSATION 12
252 WHITE BLOOD CELL COUNT DECREASED 12
253 ATRIOVENTRICULAR SEPTAL DEFECT 11
254 BLOOD GLUCOSE INCREASED 11
255 BLOOD PRESSURE DECREASED 11
256 CARDIAC FAILURE CONGESTIVE 11
257 DISEASE RECURRENCE 11
258 HAEMATOMA 11
259 HIV VIRAEMIA 11
260 INJECTION SITE EXTRAVASATION 11
261 INJECTION SITE HAEMATOMA 11
262 INJECTION SITE INDENTATION 11
263 LIVER DISORDER 11
264 LYMPHOMA 11
265 OVERDOSE 11
266 POOR QUALITY PRODUCT ADMINISTERED 11
267 ROAD TRAFFIC ACCIDENT 11
268 VISION BLURRED 11
269 WEIGHT FLUCTUATION 11
270 ADMINISTRATION SITE PAIN 10
271 ANGINA PECTORIS 10
272 BLOOD CHOLESTEROL ABNORMAL 10
273 DRY MOUTH 10
274 EPILEPSY 10
275 EYELID OEDEMA 10
276 FACIAL PARESIS 10
277 HEART DISEASE CONGENITAL 10
278 INFARCTION 10
279 INFLUENZA 10
280 LYMPHADENOPATHY 10
281 OESOPHAGEAL CARCINOMA 10
282 PANCYTOPENIA 10
283 POLYURIA 10
284 RASH MACULO-PAPULAR 10
285 RENAL DISORDER 10
286 SINGLE COMPONENT OF A TWO-COMPONENT PRODUCT ADMINISTERED 10
287 SINUSITIS 10
288 SKIN DISORDER 10
289 VERTIGO 10
290 WOUND 10
291 BK VIRUS INFECTION 9
292 BLOOD CREATINE PHOSPHOKINASE INCREASED 9
293 CONGESTIVE CARDIOMYOPATHY 9
294 CONTRAINDICATED PRODUCT ADMINISTERED 9
295 DEEP VEIN THROMBOSIS 9
296 DRUG-INDUCED LIVER INJURY 9
297 EYELID PTOSIS 9
298 FLUID RETENTION 9
299 HALLUCINATION 9
300 HEPATIC FUNCTION ABNORMAL 9
301 HEPATITIS A 9
302 HERPES ZOSTER 9
303 LOCAL REACTION 9
304 MEDICATION ERROR 9
305 MICTURITION DISORDER 9
306 NO ADVERSE EVENT 9
307 PANCREATITIS 9
308 STAPHYLOCOCCAL INFECTION 9
309 STOMATITIS 9
310 SURGERY 9
311 ABORTION INDUCED 8
312 ANAPHYLACTIC SHOCK 8
313 ASPERGILLUS INFECTION 8
314 ASTHMA 8
315 CARDIOVASCULAR DISORDER 8
316 CD4 LYMPHOCYTES INCREASED 8
317 CONFUSIONAL STATE 8
318 DEPRESSIVE SYMPTOM 8
319 ECONOMIC PROBLEM 8
320 ENURESIS 8
321 FAT TISSUE INCREASED 8
322 GENERAL PHYSICAL HEALTH DETERIORATION 8
323 HEPATIC CYTOLYSIS 8
324 HEPATITIS ACUTE 8
325 HYPERLIPIDAEMIA 8
326 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 8
327 INCORRECT PRODUCT ADMINISTRATION DURATION 8
328 INJECTION SITE CELLULITIS 8
329 INTENTIONAL PRODUCT MISUSE 8
330 LABELLED DRUG-DRUG INTERACTION ISSUE 8
331 LIVE BIRTH 8
332 LOW BIRTH WEIGHT BABY 8
333 MEMORY IMPAIRMENT 8
334 MOOD SWINGS 8
335 NEOPLASM 8
336 ORAL DISCOMFORT 8
337 PALLOR 8
338 PANCREATITIS ACUTE 8
339 PATENT DUCTUS ARTERIOSUS 8
340 PERIPHERAL COLDNESS 8
341 PRE-ECLAMPSIA 8
342 PREMATURE LABOUR 8
343 PRODUCT PRESCRIBING ERROR 8
344 SCAR 8
345 SELF-INJURIOUS IDEATION 8
346 THERAPY NON-RESPONDER 8
347 TRANSAMINASES INCREASED 8
348 VENOUS THROMBOSIS 8
349 ACUTE MYOCARDIAL INFARCTION 7
350 AGITATION 7
351 ARTHROPATHY 7
352 BASAL CELL CARCINOMA 7
353 BLOOD CHOLESTEROL INCREASED 7
354 CARDIAC DISORDER 7
355 CHLAMYDIAL INFECTION 7
356 CHOLESTASIS OF PREGNANCY 7
357 CLOSTRIDIUM DIFFICILE INFECTION 7
358 COLD SWEAT 7
359 DISORIENTATION 7
360 DISTURBANCE IN ATTENTION 7
361 EOSINOPHILIA 7
362 EYE PAIN 7
363 FEBRILE NEUTROPENIA 7
364 FOETAL GROWTH RESTRICTION 7
365 HAEMATOCHEZIA 7
366 HAEMOGLOBIN DECREASED 7
367 HELLP SYNDROME 7
368 HEPATIC CIRRHOSIS 7
369 INJECTION RELATED REACTION 7
370 INJECTION SITE ATROPHY 7
371 INJECTION SITE GRANULOMA 7
372 INJECTION SITE RASH 7
373 INJURY ASSOCIATED WITH DEVICE 7
374 JAUNDICE 7
375 MACULOPATHY 7
376 MENTAL STATUS CHANGES 7
377 MIGRAINE 7
378 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7
379 MULTIPLE-DRUG RESISTANCE 7
380 NEOPLASM MALIGNANT 7
381 OEDEMA PERIPHERAL 7
382 OSTEONECROSIS 7
383 PANCREATIC FAILURE 7
384 PARAESTHESIA ORAL 7
385 PLATELET COUNT DECREASED 7
386 POSTPARTUM HAEMORRHAGE 7
387 PREMATURE DELIVERY 7
388 PRODUCT DISTRIBUTION ISSUE 7
389 PRODUCT DOSE OMISSION IN ERROR 7
390 PRODUCTIVE COUGH 7
391 PROSTATITIS 7
392 RASH MACULAR 7
393 RHABDOMYOLYSIS 7
394 SKIN ULCER 7
395 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7
396 THERAPY CHANGE 7
397 THROAT IRRITATION 7
398 TOXIC NEUROPATHY 7
399 URINARY INCONTINENCE 7
400 ADMINISTRATION SITE DISCOMFORT 6
401 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6
402 APHASIA 6
403 ARTHRITIS 6
404 ATRIAL FLUTTER 6
405 BLOOD BILIRUBIN INCREASED 6
406 BREAST CANCER 6
407 CENTRAL VENOUS CATHETERISATION 6
408 COGNITIVE DISORDER 6
409 COLITIS 6
410 CONGENITAL AORTIC VALVE INCOMPETENCE 6
411 CRYING 6
412 DRUG ABUSE 6
413 DRUG RESISTANCE MUTATION 6
414 EMPHYSEMA 6
415 GASTRITIS 6
416 GASTROINTESTINAL TOXICITY 6
417 HEPATIC FAILURE 6
418 HEPATIC STEATOSIS 6
419 HYDRONEPHROSIS 6
420 HYPERSOMNIA 6
421 HYPONATRAEMIA 6
422 INJECTION SITE SCAR 6
423 JOINT STIFFNESS 6
424 LACRIMATION INCREASED 6
425 LIMB DISCOMFORT 6
426 LIPIDS INCREASED 6
427 LIVER INJURY 6
428 LOW DENSITY LIPOPROTEIN INCREASED 6
429 LUNG NEOPLASM MALIGNANT 6
430 MOTOR NEURONE DISEASE 6
431 MOVEMENT DISORDER 6
432 OPHTHALMIC HERPES SIMPLEX 6
433 OROPHARYNGEAL DISCOMFORT 6
434 PAPULE 6
435 PHARYNGEAL SWELLING 6
436 POLYCYTHAEMIA 6
437 PREGNANCY WITH IMPLANT CONTRACEPTIVE 6
438 PRODUCT USE COMPLAINT 6
439 RENAL COLIC 6
440 RESPIRATORY DISTRESS 6
441 SKIN ODOUR ABNORMAL 6
442 SPLENOMEGALY 6
443 SWOLLEN TONGUE 6
444 TOOTHACHE 6
445 VENTRICULAR HYPOPLASIA 6
446 VENTRICULAR SEPTAL DEFECT 6
447 ABNORMAL BEHAVIOUR 5
448 ANGER 5
449 APPENDICECTOMY 5
450 ASCITES 5
451 BIPOLAR DISORDER 5
452 BIPOLAR I DISORDER 5
453 BLOOD PRESSURE ABNORMAL 5
454 BONE PAIN 5
455 BRADYCARDIA 5
456 BRAIN FOG 5
457 BRONCHOSPASM 5
458 CD8 LYMPHOCYTES DECREASED 5
459 CHOKING 5
460 CONGENITAL TRICUSPID VALVE INCOMPETENCE 5
461 DERMATITIS EXFOLIATIVE GENERALISED 5
462 DRY EYE 5
463 DYSARTHRIA 5
464 ECTOPIC PREGNANCY 5
465 ENCEPHALOPATHY 5
466 EXTRAPYRAMIDAL DISORDER 5
467 EYE PRURITUS 5
468 FLOPPY EYELID SYNDROME 5
469 GASTRIC ULCER 5
470 GLAUCOMA 5
471 GLOMERULAR FILTRATION RATE INCREASED 5
472 HAEMORRHOIDS 5
473 HAEMORRHOIDS THROMBOSED 5
474 HEART RATE INCREASED 5
475 HELICOBACTER INFECTION 5
476 HEPATITIS B DNA INCREASED 5
477 HEPATITIS CHOLESTATIC 5
478 HERPES SIMPLEX 5
479 HYPERBILIRUBINAEMIA 5
480 HYPOPHOSPHATAEMIA 5
481 HYPOTHYROIDISM 5
482 INJECTED LIMB MOBILITY DECREASED 5
483 INJECTION SITE PLAQUE 5
484 INTENTIONAL PRODUCT USE ISSUE 5
485 MANIA 5
486 MELANODERMA 5
487 MULTIPLE INJURIES 5
488 MUSCLE TIGHTNESS 5
489 MUSCULOSKELETAL DISCOMFORT 5
490 NASAL CONGESTION 5
491 OBESITY 5
492 ORAL CANDIDIASIS 5
493 OXYGEN SATURATION DECREASED 5
494 PANIC ATTACK 5
495 PHOTOSENSITIVITY REACTION 5
496 PNEUMOCYSTIS JIROVECII PNEUMONIA 5
497 POLYNEUROPATHY 5
498 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5
499 POOR QUALITY SLEEP 5
500 PRODUCT PHYSICAL CONSISTENCY ISSUE 5
501 RASH ERYTHEMATOUS 5
502 RASH PAPULAR 5
503 RENAL TUBULAR DYSFUNCTION 5
504 RESTLESSNESS 5
505 SEPSIS 5
506 SKIN DISCOLOURATION 5
507 SPEECH DISORDER 5
508 SUDDEN DEATH 5
509 THROAT TIGHTNESS 5
510 TOXIC CARDIOMYOPATHY 5
511 TOXIC SKIN ERUPTION 5
512 TRISMUS 5
513 VACCINATION FAILURE 5
514 VENTRICULAR EXTRASYSTOLES 5
515 VIRAL LOAD 5
516 WHEEZING 5
517 ABDOMINAL PAIN LOWER 4
518 ACIDOSIS 4
519 ACUTE HEPATIC FAILURE 4
520 ALCOHOL INTOLERANCE 4
521 AMNESIA 4
522 ANGIOPATHY 4
523 AORTIC DISSECTION 4
524 APPENDICITIS 4
525 BACTERIAL SEPSIS 4
526 BEDRIDDEN 4
527 BLOOD GLUCOSE DECREASED 4
528 BLOOD TRIGLYCERIDES INCREASED 4
529 CD4 LYMPHOCYTE PERCENTAGE DECREASED 4
530 CHOLECYSTITIS ACUTE 4
531 COMA 4
532 CUSHING^S SYNDROME 4
533 DEVICE DIFFICULT TO USE 4
534 DIPLOPIA 4
535 DISEASE RISK FACTOR 4
536 DRUG TOLERANCE 4
537 DYSURIA 4
538 END STAGE RENAL DISEASE 4
539 EOSINOPHIL COUNT INCREASED 4
540 EYE SWELLING 4
541 FISTULA 4
542 FLANK PAIN 4
543 FUNGAL INFECTION 4
544 GASTROINTESTINAL HAEMORRHAGE 4
545 GASTROINTESTINAL PAIN 4
546 GLYCOSYLATED HAEMOGLOBIN INCREASED 4
547 HEAVY MENSTRUAL BLEEDING 4
548 HEPATITIS E 4
549 HEPATOCELLULAR INJURY 4
550 HIGH DENSITY LIPOPROTEIN DECREASED 4
551 HYPERTENSIVE CRISIS 4
552 HYPERTRANSAMINASAEMIA 4
553 INABILITY TO AFFORD MEDICATION 4
554 INFLAMMATION 4
555 INFUSION RELATED REACTION 4
556 INJECTION SITE BRUISING 4
557 INJECTION SITE PAPULE 4
558 INJECTION SITE PUSTULE 4
559 INJECTION SITE VESICLES 4
560 INTERCEPTED MEDICATION ERROR 4
561 IRON DEFICIENCY ANAEMIA 4
562 ISCHAEMIC STROKE 4
563 JOINT SWELLING 4
564 KAPOSI^S SARCOMA 4
565 LABORATORY TEST ABNORMAL 4
566 LEUKOCYTOSIS 4
567 LIMB INJURY 4
568 MATERNAL EXPOSURE BEFORE PREGNANCY 4
569 MENSTRUATION IRREGULAR 4
570 MOUTH ULCERATION 4
571 MYOPATHY 4
572 MYOSCLEROSIS 4
573 NEGATIVE THOUGHTS 4
574 NERVOUSNESS 4
575 OSTEOPENIA 4
576 OVERWEIGHT 4
577 PANIC REACTION 4
578 PARALYSIS 4
579 PELVIC PAIN 4
580 PERICARDITIS 4
581 PNEUMONIA LEGIONELLA 4
582 PROCTITIS 4
583 PROCTITIS CHLAMYDIAL 4
584 PRODUCT ADMINISTERED BY WRONG PERSON 4
585 PRODUCT QUALITY ISSUE 4
586 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4
587 PULMONARY ALVEOLAR HAEMORRHAGE 4
588 PULMONARY TUBERCULOSIS 4
589 PYELOCALIECTASIS 4
590 QUALITY OF LIFE DECREASED 4
591 RECTAL HAEMORRHAGE 4
592 RENAL TUBULAR DISORDER 4
593 RETINAL TOXICITY 4
594 RHINITIS ALLERGIC 4
595 RIB FRACTURE 4
596 SEASONAL ALLERGY 4
597 SENSORY LOSS 4
598 SEXUALLY TRANSMITTED DISEASE 4
599 SKIN WARM 4
600 TACHYPNOEA 4
601 TENDERNESS 4
602 THIRST 4
603 THROMBOSIS 4
604 TOOTH LOSS 4
605 TRANSIENT ISCHAEMIC ATTACK 4
606 TRANSPLANT DYSFUNCTION 4
607 TUBULOINTERSTITIAL NEPHRITIS 4
608 TYPE I HYPERSENSITIVITY 4
609 VARICELLA 4
610 VASCULITIS 4
611 ACCIDENTAL OVERDOSE 3
612 ACUTE CORONARY SYNDROME 3
613 ACUTE PSYCHOSIS 3
614 ACUTE RESPIRATORY FAILURE 3
615 ADMINISTRATION SITE INDURATION 3
616 ADMINISTRATION SITE WARMTH 3
617 AFFECTIVE DISORDER 3
618 AGRANULOCYTOSIS 3
619 AIDS RELATED COMPLICATION 3
620 ALANINE AMINOTRANSFERASE ABNORMAL 3
621 ALBUMINURIA 3
622 ANAL INCONTINENCE 3
623 APHTHOUS ULCER 3
624 ARRHYTHMIA 3
625 ARTERIOSCLEROSIS CORONARY ARTERY 3
626 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3
627 AUTOIMMUNE HEPATITIS 3
628 B-CELL LYMPHOMA 3
629 BELL^S PALSY 3
630 BETA 2 MICROGLOBULIN URINE INCREASED 3
631 BLOOD ALKALINE PHOSPHATASE INCREASED 3
632 BLOOD CREATININE DECREASED 3
633 BLOOD HIV RNA BELOW ASSAY LIMIT 3
634 BLOOD POTASSIUM INCREASED 3
635 BODY DYSMORPHIC DISORDER 3
636 BODY MASS INDEX DECREASED 3
637 BODY TEMPERATURE INCREASED 3
638 BONE DENSITY DECREASED 3
639 BRAIN DEATH 3
640 BRONCHITIS 3
641 CARDIO-RESPIRATORY ARREST 3
642 CATARACT 3
643 CERVICAL DYSPLASIA 3
644 CHOLANGITIS 3
645 CHROMATURIA 3
646 CONCOMITANT DISEASE AGGRAVATED 3
647 CONGENITAL HYDRONEPHROSIS 3
648 CONJUNCTIVAL HYPERAEMIA 3
649 CORONAVIRUS INFECTION 3
650 CORONAVIRUS TEST POSITIVE 3
651 CSF HIV ESCAPE SYNDROME 3
652 CYTOPENIA 3
653 DELUSION 3
654 DERMATITIS ALLERGIC 3
655 DEVICE USE ERROR 3
656 DIABETES MELLITUS INADEQUATE CONTROL 3
657 DIABETIC KETOACIDOSIS 3
658 DISCHARGE 3
659 DISEASE PROGRESSION 3
660 DISSOCIATION 3
661 DRUG MONITORING PROCEDURE NOT PERFORMED 3
662 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
663 DYSSTASIA 3
664 ECCHYMOSIS 3
665 ECZEMA 3
666 EMOTIONAL DISORDER 3
667 ENCAPSULATION REACTION 3
668 EPISTAXIS 3
669 ESCHERICHIA BACTERAEMIA 3
670 ESSENTIAL HYPERTENSION 3
671 EXPOSURE TO COMMUNICABLE DISEASE 3
672 EXTRAOCULAR MUSCLE DISORDER 3
673 EYE IRRITATION 3
674 FACE OEDEMA 3
675 FACIAL ASYMMETRY 3
676 FACIAL PAIN 3
677 FAT NECROSIS 3
678 FEELING COLD 3
679 FEELING OF BODY TEMPERATURE CHANGE 3
680 FLATULENCE 3
681 FOLATE DEFICIENCY 3
682 FOOD POISONING 3
683 FOOT FRACTURE 3
684 GASTROENTERITIS 3
685 GENOTYPE DRUG RESISTANCE TEST POSITIVE 3
686 GLUCOSE TOLERANCE IMPAIRED 3
687 GONORRHOEA 3
688 GOUT 3
689 HAEMOGLOBIN INCREASED 3
690 HAEMOPTYSIS 3
691 HEAD DISCOMFORT 3
692 HEAD INJURY 3
693 HEART RATE IRREGULAR 3
694 HERPES VIRUS INFECTION 3
695 HYPERAESTHESIA 3
696 HYPERKALAEMIA 3
697 HYPERTHYROIDISM 3
698 HYPERURICAEMIA 3
699 HYPOGONADISM 3
700 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 3
701 HYPOXIA 3
702 IMMUNOSUPPRESSION 3
703 INCORRECT DOSE ADMINISTERED BY DEVICE 3
704 INJECTION SITE CYST 3
705 INJECTION SITE DISCOLOURATION 3
706 INJECTION SITE HYPERSENSITIVITY 3
707 INJECTION SITE HYPOAESTHESIA 3
708 INJECTION SITE SCAB 3
709 INTERCEPTED PRODUCT STORAGE ERROR 3
710 LIPOATROPHY 3
711 LIVER FUNCTION TEST ABNORMAL 3
712 LOWER RESPIRATORY TRACT INFECTION 3
713 LUPUS-LIKE SYNDROME 3
714 MALIGNANT NEOPLASM PROGRESSION 3
715 MALNUTRITION 3
716 MORNING SICKNESS 3
717 MUSCLE DISORDER 3
718 MUSCLE FATIGUE 3
719 MUSCLE HYPERTROPHY 3
720 MUSCLE RUPTURE 3
721 MUSCULOSKELETAL DISORDER 3
722 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3
723 MYOSITIS 3
724 NEONATAL ASPHYXIA 3
725 NERVE INJURY 3
726 NEUTROPENIC SEPSIS 3
727 NEUTROPHIL COUNT DECREASED 3
728 OLIGURIA 3
729 OPTIC NEURITIS 3
730 ORAL HERPES 3
731 OROPHARYNGEAL GONOCOCCAL INFECTION 3
732 PANCREATIC CARCINOMA 3
733 PAPILLOMA 3
734 PATIENT DISSATISFACTION WITH TREATMENT 3
735 PERINATAL HIV INFECTION 3
736 PIGMENTATION DISORDER 3
737 PLATELET COUNT INCREASED 3
738 PNEUMONIA ASPIRATION 3
739 POLLAKIURIA 3
740 POST-TRAUMATIC STRESS DISORDER 3
741 PREGNANCY ON ORAL CONTRACEPTIVE 3
742 PRIMARY HYPOGONADISM 3
743 PRODUCT COMMUNICATION ISSUE 3
744 PRODUCT PHYSICAL ISSUE 3
745 PRODUCT TASTE ABNORMAL 3
746 PSEUDO CUSHING^S SYNDROME 3
747 PSORIASIS 3
748 PULMONARY MASS 3
749 QUARANTINE 3
750 RENAL INFARCT 3
751 RENAL INJURY 3
752 RESPIRATORY ACIDOSIS 3
753 RETINAL PIGMENTATION 3
754 RHEUMATOID ARTHRITIS 3
755 SEPTIC SHOCK 3
756 SKIN ABRASION 3
757 SKIN BURNING SENSATION 3
758 SKIN HYPERPIGMENTATION 3
759 SKIN INDURATION 3
760 SKIN LACERATION 3
761 SKIN REACTION 3
762 SNEEZING 3
763 SPINAL FRACTURE 3
764 SPINAL OPERATION 3
765 STEVENS-JOHNSON SYNDROME 3
766 SUBSTANCE USE DISORDER 3
767 SYRINGE ISSUE 3
768 T-LYMPHOCYTE COUNT DECREASED 3
769 TACHYPHRENIA 3
770 THERAPY INTERRUPTED 3
771 TINNITUS 3
772 UNDERWEIGHT 3
773 UNINTENDED PREGNANCY 3
774 UPPER RESPIRATORY TRACT INFECTION 3
775 URINE OUTPUT DECREASED 3
776 UVEITIS 3
777 VENTRICULAR TACHYCARDIA 3
778 VIRAL LOAD DECREASED 3
779 VITAMIN D DEFICIENCY 3
780 ABSCESS STERILE 2
781 ACARODERMATITIS 2
782 ACQUIRED IMMUNODEFICIENCY SYNDROME 2
783 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 2
784 ADMINISTRATION SITE NECROSIS 2
785 ADMINISTRATION SITE OEDEMA 2
786 ADNEXA UTERI CYST 2
787 ADVERSE REACTION 2
788 AMNIOTIC CAVITY INFECTION 2
789 ANAL CANCER 2
790 ANAPHYLACTOID REACTION 2
791 ANGIOMYOLIPOMA 2
792 ANORECTAL DISORDER 2
793 ANTIVIRAL DRUG LEVEL ABOVE THERAPEUTIC 2
794 APATHY 2
795 AREFLEXIA 2
796 ARTERIOSCLEROSIS 2
797 ASPARTATE AMINOTRANSFERASE ABNORMAL 2
798 ASPHYXIA 2
799 ASPIRATION 2
800 ASTHMATIC CRISIS 2
801 ATRIAL SEPTAL DEFECT 2
802 ATYPICAL PNEUMONIA 2
803 BACK DISORDER 2
804 BACTERIAL INFECTION 2
805 BALANCE DISORDER 2
806 BENIGN ETHNIC NEUTROPENIA 2
807 BENIGN PROSTATIC HYPERPLASIA 2
808 BLADDER DISCOMFORT 2
809 BLISTER 2
810 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2
811 BLOOD CATECHOLAMINES ABNORMAL 2
812 BLOOD GLUCOSE ABNORMAL 2
813 BLOOD IMMUNOGLOBULIN E INCREASED 2
814 BLOOD KETONE BODY INCREASED 2
815 BLOOD POTASSIUM DECREASED 2
816 BLOOD TESTOSTERONE DECREASED 2
817 BONE MARROW FAILURE 2
818 BOWEL MOVEMENT IRREGULARITY 2
819 BRAIN INJURY 2
820 BREAST NEOPLASM 2
821 CARDIAC FIBRILLATION 2
822 CARDIOPULMONARY FAILURE 2
823 CARDIOVASCULAR SYMPTOM 2
824 CATHETER REMOVAL 2
825 CD4 LYMPHOCYTES ABNORMAL 2
826 CD4/CD8 RATIO DECREASED 2
827 CD4/CD8 RATIO INCREASED 2
828 CENTRAL OBESITY 2
829 CHEST INJURY 2
830 CHOLECYSTECTOMY 2
831 CHRONIC ACTINIC DERMATITIS 2
832 CHRONIC GASTRITIS 2
833 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
834 CIRCULATORY COLLAPSE 2
835 CLAVICLE FRACTURE 2
836 CLUMSINESS 2
837 CLUSTER HEADACHE 2
838 COLON CANCER 2
839 COMPLICATION OF PREGNANCY 2
840 CONJUNCTIVITIS 2
841 CONTRAINDICATED PRODUCT PRESCRIBED 2
842 CORONARY ARTERY STENOSIS 2
843 COUGH VARIANT ASTHMA 2
844 CRANIOCEREBRAL INJURY 2
845 CREATINE KINASE INCREASED 2
846 CROHN^S DISEASE 2
847 CSF VIRUS IDENTIFIED 2
848 CUSHINGOID 2
849 CUTANEOUS VASCULITIS 2
850 CYST 2
851 CYTOMEGALOVIRUS INFECTION 2
852 DEAFNESS 2
853 DECREASED ACTIVITY 2
854 DEFAECATION URGENCY 2
855 DERMAL CYST 2
856 DIABETIC COMA 2
857 DIARRHOEA HAEMORRHAGIC 2
858 DRUG CLEARANCE DECREASED 2
859 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2
860 DRUG LEVEL BELOW THERAPEUTIC 2
861 DYSGRAPHIA 2
862 DYSKINESIA 2
863 DYSLEXIA 2
864 DYSPHONIA 2
865 DYSPHORIA 2
866 DYSPNOEA EXERTIONAL 2
867 EAR DISCOMFORT 2
868 ELECTROCARDIOGRAM T WAVE INVERSION 2
869 EOSINOPHILIC OESOPHAGITIS 2
870 EOSINOPHILIC PNEUMONIA 2
871 ERUCTATION 2
872 EXPIRED PRODUCT ADMINISTERED 2
873 EYE PARAESTHESIA 2
874 FACIAL WASTING 2
875 FAECES DISCOLOURED 2
876 FEAR OF INJECTION 2
877 FEELING JITTERY 2
878 FEELING OF DESPAIR 2
879 FEMORAL NERVE INJURY 2
880 FIBROSIS 2
881 FINE MOTOR SKILL DYSFUNCTION 2
882 FOETAL DEATH 2
883 FRACTURE 2
884 FURUNCLE 2
885 GALLBLADDER AGENESIS 2
886 GALLBLADDER DISORDER 2
887 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 2
888 GASTRIC ADENOMA 2
889 GASTRIC HAEMORRHAGE 2
890 GASTRIC OPERATION 2
891 GASTRIC ULCER PERFORATION 2
892 GASTROENTERITIS VIRAL 2
893 GENERALISED TONIC-CLONIC SEIZURE 2
894 GENITAL HERPES 2
895 GESTATIONAL DIABETES 2
896 GINGIVAL PAIN 2
897 GRAFT COMPLICATION 2
898 GRANULOMATOUS DERMATITIS 2
899 GROIN PAIN 2
900 HAEMATOCRIT INCREASED 2
901 HAEMATOMA MUSCLE 2
902 HAEMATOSPERMIA 2
903 HAEMATURIA 2
904 HAEMOLYTIC ANAEMIA 2
905 HAEMORRHAGE INTRACRANIAL 2
906 HAEMORRHAGIC STROKE 2
907 HAND FRACTURE 2
908 HELICOBACTER GASTRITIS 2
909 HEPATITIS B ANTIGEN POSITIVE 2
910 HEPATITIS B CORE ANTIBODY POSITIVE 2
911 HEPATITIS B SURFACE ANTIBODY POSITIVE 2
912 HEPATITIS SYPHILITIC 2
913 HEPATITIS VIRAL 2
914 HEPATOCELLULAR CARCINOMA 2
915 HERNIA 2
916 HIP FRACTURE 2
917 HIV INFECTION 2
918 HLA-B*5701 ASSAY POSITIVE 2
919 HODGKIN^S DISEASE MIXED CELLULARITY STAGE UNSPECIFIED 2
920 HOSPICE CARE 2
921 HYPERCHOLESTEROLAEMIA 2
922 HYPERPROLACTINAEMIA 2
923 HYPERPYREXIA 2
924 HYPOACUSIS 2
925 HYPOGLYCAEMIA 2
926 HYPOMETABOLISM 2
927 HYPOTONIA 2
928 ILEUS 2
929 IMMEDIATE POST-INJECTION REACTION 2
930 IMMUNE SYSTEM DISORDER 2
931 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2
932 IMPAIRED HEALING 2
933 IMPAIRED WORK ABILITY 2
934 INCORRECT DISPOSAL OF PRODUCT 2
935 INCORRECT DOSAGE ADMINISTERED 2
936 INCREASED TENDENCY TO BRUISE 2
937 INFECTION SUSCEPTIBILITY INCREASED 2
938 INJECTION SITE FIBROSIS 2
939 INJECTION SITE IRRITATION 2
940 INJECTION SITE MOVEMENT IMPAIRMENT 2
941 INJECTION SITE MUSCLE ATROPHY 2
942 INJECTION SITE PANNICULITIS 2
943 INJECTION SITE PARAESTHESIA 2
944 INJECTION SITE URTICARIA 2
945 INJURY 2
946 INTENTIONAL DOSE OMISSION 2
947 INTENTIONAL OVERDOSE 2
948 INTENTIONAL SELF-INJURY 2
949 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2
950 INTERCEPTED PRODUCT DISPENSING ERROR 2
951 INTERCEPTED PRODUCT SELECTION ERROR 2
952 INTERSTITIAL LUNG DISEASE 2
953 INTESTINAL OBSTRUCTION 2
954 INTRACRANIAL PRESSURE INCREASED 2
955 JANEWAY LESION 2
956 JOINT EFFUSION 2
957 JOINT INJURY 2
958 KELOID SCAR 2
959 LARYNGEAL NEOPLASM 2
960 LARYNGEAL STENOSIS 2
961 LIBIDO DECREASED 2
962 LICHEN PLANUS 2
963 LIPOHYPERTROPHY 2
964 LIPOMA 2
965 LIVER ABSCESS 2
966 LOSS OF LIBIDO 2
967 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 2
968 LUMBAR SPINAL STENOSIS 2
969 LUNG DISORDER 2
970 LUNG NEOPLASM 2
971 LYMPHOMA AIDS RELATED 2
972 LYMPHOPENIA 2
973 MACULE 2
974 MALABSORPTION FROM ADMINISTRATION SITE 2
975 MALABSORPTION FROM INJECTION SITE 2
976 MANUFACTURING PRODUCT SHIPPING ISSUE 2
977 MARASMUS 2
978 MEAN CELL VOLUME DECREASED 2
979 MEASLES 2
980 MENINGIOMA 2
981 MENINGOCOCCAL INFECTION 2
982 MENSTRUAL DISORDER 2
983 METABOLIC ACIDOSIS 2
984 METABOLIC SURGERY 2
985 MIDDLE INSOMNIA 2
986 MONOCLONAL IMMUNOGLOBULIN INCREASED 2
987 MONOPLEGIA 2
988 MOTOR DYSFUNCTION 2
989 MOUTH SWELLING 2
990 MULTI-ORGAN FAILURE 2
991 MUSCLE CONTRACTIONS INVOLUNTARY 2
992 MUSCULOSKELETAL CHEST PAIN 2
993 MYCOBACTERIAL INFECTION 2
994 MYCOPLASMA INFECTION 2
995 MYELOSUPPRESSION 2
996 MYOCARDITIS 2
997 NASAL VESTIBULITIS 2
998 NEPHRECTOMY 2
999 NEPHROGENIC ANAEMIA 2